Published in Epidemiol Rev on January 01, 1988
Report of a National Workshop on Screening for Cancer of the Cervix. CMAJ (1991) 5.37
Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci U S A (1995) 4.15
Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J Virol (1993) 4.00
Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol (1993) 3.65
Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect (2004) 2.76
Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol (1992) 2.60
Sexually transmitted diseases in children: adolescents. Genitourin Med (1993) 2.27
Epidemiology and causation: a realist view. J Epidemiol Community Health (1994) 1.99
Women with multiple sexual partners: united states, 1988. Am J Public Health (1992) 1.73
Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women. J Clin Microbiol (1992) 1.64
Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother (1998) 1.47
Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol (2003) 1.45
Genital warts: a comprehensive review. J Clin Aesthet Dermatol (2012) 1.40
Effect of concurrent lower genital tract infections on cervical cancer screening. Genitourin Med (1997) 1.30
Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American, and non-Hispanic white women in New Mexico. Am J Public Health (1991) 1.29
Pyogenic granuloma of the penis--a rare entity? Genitourin Med (1995) 1.27
Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay. J Clin Microbiol (1990) 1.15
Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine. J Virol (2002) 1.08
Recurrent respiratory papillomatosis: an overview of current thinking and treatment. Eur Arch Otorhinolaryngol (2007) 1.08
Barriers to cervical cancer screening among lesbians. J Womens Health (Larchmt) (2010) 1.08
Cervical cancer incidence and mortality in New Mexico's Hispanics, American Indians, and non-Hispanic whites. West J Med (1992) 1.06
A method for identifying persons at high risk for sexually transmitted infections: opportunity for targeting intervention. Am J Public Health (1993) 1.06
Development of therapeutic HPV vaccines. Lancet Oncol (2009) 1.04
Cervicovaginal screening in women with HIV infection: a need for increased vigilance? CMAJ (1994) 1.02
Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18. J Virol (1991) 1.01
Strategies for fostering HPV vaccine acceptance. Infect Dis Obstet Gynecol (2006) 0.97
Genital papillomaviruses, polymerase chain reaction and cervical cancer. Genitourin Med (1990) 0.93
A novel genital human papillomavirus (HPV), HPV type 74, found in immunosuppressed patients. J Clin Microbiol (1996) 0.91
Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris. Arch Virol (2009) 0.89
Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease. Hum Genet (2005) 0.88
Hand-genital transmission of genital warts? An analysis of prevalence data. Epidemiol Infect (1995) 0.87
Umbilical warts: a new entity? Genitourin Med (1994) 0.87
Cervical cancer treatment with a locally insertable controlled release delivery system. J Control Release (2006) 0.86
Sexually transmitted diseases and native Americans: trends in reported gonorrhea and syphilis morbidity, 1984-88. Public Health Rep (1990) 0.86
Female genital warts: global trends and treatments. Infect Dis Obstet Gynecol (2001) 0.84
Anal Cancer Screening: Barriers and Facilitators Among Ethnically Diverse Gay, Bisexual, Transgender, and Other Men Who Have Sex With Men. J Gay Lesbian Soc Serv (2008) 0.84
Economic burden of human papillomavirus-related diseases in Italy. PLoS One (2012) 0.83
Reducing the health burden of HPV infection through vaccination. Infect Dis Obstet Gynecol (2006) 0.83
Human papillomaviruses: shared and distinct pathways for pathogenesis. Curr Opin Virol (2015) 0.82
Epidemiological aspects of genital warts in romania - a 2012 retrospective survey. Maedica (Buchar) (2014) 0.81
Human papillomavirus type 16 E7 DNA vaccine: mutation in the open reading frame of E7 enhances specific cytotoxic T-lymphocyte induction and antitumor activity. J Virol (1999) 0.81
Cervical cancer: developments in screening and evaluation of the abnormal Pap smear. West J Med (1998) 0.81
Historical review of the causes of cancer. World J Clin Oncol (2016) 0.79
Overview: viral agents and cancer. Environ Health Perspect (1995) 0.79
Evaluating human papillomavirus vaccination programs in Canada: should provincial healthcare pay for voluntary adult vaccination? BMC Public Health (2008) 0.79
CD4+ cell count and HIV load as predictors of size of anal warts over time in HIV-infected women. J Infect Dis (2012) 0.78
Development of an IP-Free Biotechnology Platform for Constitutive Production of HPV16 L1 Capsid Protein Using the Pichia pastoris PGK1 Promoter. Biomed Res Int (2015) 0.78
Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells. J Virol (1995) 0.78
Prevalence and seroprevalence of low-risk human papillomavirus in Korean women. J Korean Med Sci (2012) 0.78
Human papillomavirus infection in vulvar lesions of lichen sclerosus et atrophicus. Arch Dermatol Res (1991) 0.78
Anogenital human papillomavirus infection. Changes in understanding and management. Can Fam Physician (1994) 0.77
Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis. Clin Microbiol Rev (1991) 0.77
Rome Consensus Conference - statement; human papilloma virus diseases in males. BMC Public Health (2013) 0.77
The management of minor degrees of cervical dysplasia associated with the human papilloma virus. Yale J Biol Med (1992) 0.77
Expanding the scope of nursing research in low resource and middle resource countries, regions, and states focused on cervical cancer prevention, early detection, and control. J Natl Black Nurses Assoc (2009) 0.75
Association between smoking and size of anal warts in HIV-infected women. Int J STD AIDS (2012) 0.75
Prevalence of genital human papillomavirus infection in Wellington women. Genitourin Med (1992) 0.75
Clinical implications of the cervical Papanicolaou test results in the management of anal warts in HIV-infected women. PLoS One (2013) 0.75
Molecular genotyping of human papillomavirus l1 gene in low-risk and high-risk populations in Bangkok. Sex Transm Dis (2015) 0.75
Warts (genital). BMJ Clin Evid (2010) 0.75
Warts (genital). BMJ Clin Evid (2007) 0.75
Frequency of sexually transmitted diseases among university students. CMAJ (1993) 0.75
Cutaneous infections and infestations: new therapies. J Clin Aesthet Dermatol (2011) 0.75
Dual genitotropic human papillomavirus infections in genital warts. Genitourin Med (1993) 0.75
[Cervix carcinoma--Austrian Vaccination Committee recommends HPV vaccination]. Wien Med Wochenschr (2007) 0.75
Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial. Wien Klin Wochenschr (2008) 0.75
Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med (1983) 16.63
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med (1996) 11.91
Etiology of nongonococcal urethritis. N Engl J Med (1975) 9.61
Diagnosis of coliform infection in acutely dysuric women. N Engl J Med (1982) 8.75
Characterization of plasmid deoxyribonucleic acid from Neisseria gonorrhoeae. Infect Immun (1974) 8.30
Disseminated gonococcal infections caused by Neisseria gonorrhoeae with unique nutritional requirements. J Infect Dis (1975) 7.92
Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med (1983) 7.89
The serological classification of Neisseria gonorrhoeae. I. Isolation of the outer membrane complex responsible for serotypic specificity. J Exp Med (1976) 7.85
Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature (1998) 7.81
Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med (1978) 7.07
Causes of the acute urethral syndrome in women. N Engl J Med (1980) 6.91
Anaerobic bacteria in nonspecific vaginitis. N Engl J Med (1980) 6.74
Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J Infect Dis (1985) 6.32
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96
Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance. N Engl J Med (1974) 5.68
Disseminated gonococcal infection. Ann Intern Med (1971) 5.66
Serological classification of Neisseria gonorrhoeae with monoclonal antibodies. Infect Immun (1982) 5.54
Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera. J Clin Invest (1976) 5.54
Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis (1984) 5.40
Clinical spectrum of pharyngeal gonococcal infection. N Engl J Med (1973) 5.34
A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med (1988) 5.32
Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med (1975) 4.99
Quantitative determination of antibody to gonococcal pili. Changes in antibody levels with gonococcal infection. J Clin Invest (1973) 4.90
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74
AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med (1986) 4.68
Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA (1986) 4.62
Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med (1996) 4.51
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42
Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol (1983) 4.42
Selective differential human blood bilayer media for isolation of Gardnerella (Haemophilus) vaginalis. J Clin Microbiol (1982) 4.28
Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol (1996) 4.25
Characterization of Campylobacter-like organisms isolated from homosexual men. J Infect Dis (1984) 4.23
Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23
The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol (1991) 4.18
Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol (1989) 4.03
Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol (1986) 3.67
A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med (1982) 3.66
Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol (1988) 3.66
Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother (1985) 3.66
Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol (1993) 3.65
Isolation of viruses, bacteria and other organisms from venereal disease clinic patients: methodology and problems associated with multiple isolations. Health Lab Sci (1973) 3.62
Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med (1992) 3.56
Low antibiotic resistance of gonococci causing disseminated infection. N Engl J Med (1973) 3.48
An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol (1970) 3.46
Evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother (1973) 3.44
Studies of venereal disease. 3. Double-blind comparison of tetracycline hydrochloride and placebo in treatment of nongonococcal urethritis. JAMA (1967) 3.40
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis (2000) 3.36
The Chlamydia epidemic. JAMA (1981) 3.35
Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N Engl J Med (1980) 3.33
Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med (1981) 3.32
National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA (1990) 3.25
Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis (1996) 3.23
Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun (1983) 3.22
Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum. J Clin Invest (1977) 3.18
Chlamydia trachomatis as a cause of acute "idiopathic" epididymitis. N Engl J Med (1978) 3.16
Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect (2006) 3.16
The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12
DNA hybridization technique for the detection of Neisseria gonorrhoeae in men with urethritis. J Infect Dis (1983) 3.11
Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody. J Clin Microbiol (1975) 3.03
Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02
Clinical manifestations of vaginal trichomoniasis. JAMA (1989) 2.97
Identification of Gardnerella (Haemophilus) vaginalis. J Clin Microbiol (1982) 2.96
Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med (1984) 2.89
Studies of venereal disease. II. Observations on the incidence, etiology, and treatment of the postgonococcal urethritis syndrome. JAMA (1967) 2.84
Problems, solutions, and challenges in syndromic management of sexually transmitted diseases. Sex Transm Infect (1998) 2.83
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology (1996) 2.83
Sexual mixing patterns of patients attending sexually transmitted diseases clinics. Sex Transm Dis (1996) 2.76
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
Sexually transmitted diseases in victims of rape. N Engl J Med (1990) 2.74
Sexual bridging by Cambodian men: potential importance for general population spread of STD and HIV epidemics. Sex Transm Dis (2000) 2.66
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev (1997) 2.65
Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65
Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis (1985) 2.64
Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol (1998) 2.64
The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol (1992) 2.61
Single oral dose ampicillin-probenecid treatment of gnorrhea in the male. JAMA (1971) 2.56
Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA (1982) 2.55
Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules. Infect Immun (1982) 2.55
Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health (1999) 2.54
Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations. Ann Intern Med (1984) 2.44
Spectinomycin versus tetracycline for the treatment of gonorrhea. N Engl J Med (1977) 2.44
Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis (1989) 2.41
Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA (1993) 2.41
Asymptomatic gonorrhea in men: caused by gonococci with unique nutritional requirements. Science (1977) 2.37
Epidemiology of penicillinase-producing Neisseria gonorrhoeae infections: analysis by auxotyping and serogrouping. N Engl J Med (1982) 2.36
Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention. Ann Intern Med (1983) 2.33
Prevalence and characterization of hippurate-negative Campylobacter jejuni in King County, Washington. J Clin Microbiol (1987) 2.33
Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol (1977) 2.31
Spectinomycin and penicillin G in the treatment of gonorrhea. A comparative evaluation. JAMA (1972) 2.30
Epidemiology of gonorrhea: distribution and temporal changes in auxotype/serovar classes of Neisseria gonorrhoeae. Sex Transm Dis (1987) 2.27
Circumcision and sexually transmitted diseases. Am J Public Health (1994) 2.27
The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature (1983) 2.26
Amine content of vaginal fluid from untreated and treated patients with nonspecific vaginitis. J Clin Invest (1979) 2.25
Single doses of methacycline and doxycycline for gonorrhea: a cooperative study of the frequency and cause of treatment failure. J Infect Dis (1973) 2.23
Gonococcal infections. Ann Intern Med (1985) 2.23